Influenza Vaccine in Lung Transplant Patients - Antibody

Completed

Conditions studied: Influenza

In brief

This is a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This prospective, parallel study was done to investigate the responses to influenza vaccine in consecutive years.

Key facts

Study ID

NCT04533139

Run by

University of Wisconsin, Madison

People needed

122

Starts

2004-12-01

Expected to finish

2009-07-01

Last updated by the study team

2020-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Receiving care pre- or post-lung transplant at University of Wisconsin Hospital
• Healthy adult

You may not qualify if…

• Allergy to eggs
• Moderate to severe febrile illness
• Active treatment for acute rejection
• Received season's influenza vaccine prior to enrollment

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.